Eight-day Inpatient Directly Observed Therapy for Antiretroviral Therapy (ART) Failure: A Tool For Preventing Unnecessary ART Changes and Optimizing Adherence Support.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
03 03 2020
Historique:
received: 03 04 2019
accepted: 10 07 2019
pubmed: 13 7 2019
medline: 7 1 2021
entrez: 13 7 2019
Statut: ppublish

Résumé

Eight-day inpatient directly observed therapy confirmed nonadherence as the major cause of virologic failure for 9 (45%) of 20 highly treatment-experienced persons with human immunodeficiency virus, extensive antiretroviral drug resistance, and high self-reported adherence rates, preventing unnecessary regimen changes.

Identifiants

pubmed: 31298273
pii: 5531519
doi: 10.1093/cid/ciz590
pmc: PMC7319057
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1222-1225

Subventions

Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States

Informations de copyright

Published by Oxford University Press for the Infectious Diseases Society of America 2019.

Références

Antivir Ther. 2019;24(3):153-165
pubmed: 30614788
AIDS Res Hum Retroviruses. 2008 May;24(5):685-94
pubmed: 18462083
Lancet HIV. 2017 Jan;4(1):e31-e40
pubmed: 27863996
Emerg Infect Dis. 2016 Mar;22(3):538-40
pubmed: 26891363
Clin Infect Dis. 2006 Jun 1;42(11):1608-18
pubmed: 16652319
Ann Intern Med. 2018 Sep 18;169(6):376-384
pubmed: 30140916
J Med Internet Res. 2018 Nov 20;20(11):e287
pubmed: 30459146
Clin Infect Dis. 2016 Jun 15;62(12):1595-1603
pubmed: 26951573
Top Antivir Med. 2017 Dec/Jan;24(4):132-133
pubmed: 28208121

Auteurs

Nicole E Winchester (NE)

National Institute of Allergy and Infectious Diseases, Bethesda.

Frank Maldarelli (F)

National Cancer Institute, Frederick.

Yolanda Mejia (Y)

Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, National Cancer Institute, Bethesda, Maryland.

Nicola Dee (N)

Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, National Cancer Institute, Bethesda, Maryland.

Robin Dewar (R)

Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, National Cancer Institute, Bethesda, Maryland.

Elizabeth Laidlaw (E)

National Institute of Allergy and Infectious Diseases, Bethesda.

Safia S Kuriakose (SS)

Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, National Cancer Institute, Bethesda, Maryland.

Pamela Stoll (P)

Clinical Center, National Institutes of Health, Bethesda, Maryland.

Michael Proschan (M)

National Institute of Allergy and Infectious Diseases, Bethesda.

H Clifford Lane (HC)

National Institute of Allergy and Infectious Diseases, Bethesda.

Alice K Pau (AK)

National Institute of Allergy and Infectious Diseases, Bethesda.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH